GSK PLC closed 19.70% below its 52-week high of £16.79, which the company achieved on September 9th.

In a surprise, a FDA advisory panel voted that risks tied to a GSK blood cancer drug called Blenrep outweighed the benefits ...

The FDA’s Oncologic Drugs Advisory Committee has voted against the benefit/risk profile of GSK’s Blenrep just days before the drug’s PDUFA date.

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

US stocks rose on Thursday with Microsoft edging closer to a $4tn market cap, following Nvidia which reached the milestone ...

There is still no effective vaccine or cure for HIV. Scientists are considering options ranging from longer-term antiretroviral therapy (ART) that space out injections by several years to long-lasting ...

Barclays is warning that markets face “negative summer seasonality,” as August and September typically bring elevated ...

The provider of health, safety, hygiene and environmental consultancy and security solutions reported a pretax loss of GBP127,419 for the year to the end of March, swinging from a profit of GBP332,317 ...